High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimerâ €™ s disease

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Plascencia Villa, Germán ^a   Ponce, Arturo ^a   Collingwood, Joanna F ^b   Josefina Arellano Jimenez M ^a   Zhu, Xiongwei ^c   Rogers, Jack T ^d   Betancourt, Israel ^a   José Yacamán, Miguel ^a   Perry, George ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; MAGNETITE;

ALZHEIMER DISEASE; BRAIN; FLUORESCENCE IMAGING; HOLOGRAPHY; HUMAN; PATHOLOGY; SPECTROSCOPY;

ALZHEIMER DISEASE; AMYLOID; BRAIN; FERROSOFERRIC OXIDE; HOLOGRAPHY; HUMANS; OPTICAL IMAGING; SPECTRUM ANALYSIS;

EID: 84964916171     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24873     Document Type: Article

References (63)

1. Alzheimer's Disease Education and Referral (ADEAR) Center. Alzheimer's Disease Fact Sheet-National Institute on Aging. NIH Publication 15-6423, 1-8 (2015), Available at: https://www.nia.nih.gov/alzheimers/publication/alzheimers-disease-fact-sheet (Update: 07/01/2016) (Access: 03/03/2016).
2. Bush, A. I. The metallobiology of Alzheimer's disease. Trends Neurosci 26, 207-214 (2003), 10.1016/S0166-2236(03)00067-5.
3. Moreira, P. I., Carvalho, C, Zhu, X., Smith, M. A. & Perry, G. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochim Biophys Acta 1802, 2-10 (2010), 10.1016/j.bbadis.2009.10.006.
4. Wang, X. et al. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim Biophys Acta 1842, 1240-1247 (2014), 10.1016/j.bbadis.2013.10.015.
5. Bird, T. D.Alzheimer Disease Overview. GeneReviews (2015), Available at: http://www.ncbi.nlm.nih.gov/books/NBKl 16/(Update: 24/09/2015) (Access: 03/03/2016).
6. De Jager, P. L. et al Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci 17, 1156-1163 (2014), 10.1038/nn.3786.
7. Lord, J. &Cruchaga, C. The epigenetic landscape of Alzheimer's disease. Nat Neurosci 17, 1138-1140 (2014), 10.1038/nn.3792.
8. Wyss-Coray, T. & Rogers, J. Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2, a006346 (2012), 10.1101/cshperspect.a006346.
9. Roberts, B. R., Ryan, T. M., Bush, A. I., Masters, C. L. & Duce, J. A. The role of metallobiology and amyloid-beta peptides in Alzheimer's disease. JNeurochem 120, Suppl 1, 149-166(2012), 10.111 l/j.1471-4159.2011.07500.x.
10. Cho, H. H. et al Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. J Biol Chem 285, 31217-31232 (2010), 10.1074/jbc.MllO.149161.
11. Greenough, M. A., Camakaris, J. & Bush, A. I. Metal dyshomeostasis and oxidative stress in Alzheimer's disease. Neurochem Int 62, 540-555 (2013), 10.1016/j.neuint.2012.08.014.
12. Pal, A., Siotto, M., Prasad, R. & Squitti, R. Towards a unified vision of copper involvement in Alzheimer's disease: a review connecting basic, experimental, and clinical research. J Alzheimers Dis 44, 343-354 (2015), 10.3233/JAD-141194.
13. Rogers, J. &Munro, H. Translation of ferritin light and heavy subunit mRNAs is regulated by intracellular chelatable iron levels in rat hepatoma cells. Proc Natl Acad Sci USA 84, 2277-2281 (1987), 10.1073/pnas.84.8.2277.
14. Duce, J. A. et al Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857-867 (2010), 10.1016/j.cell.2010.08.014.
15. Nel, A. E. et al Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8, 543-557 (2009), 10.1038/nmat2442.
16. Pennycook, S. J. Scanning transmission electron microscopy: Seeing the atoms more clearly. MRS Bulletin 37, 943-951 (2012), 10.1557/mrs.2012.239.
17. Pennycook, S. J. Seeing the atoms more clearly: STEM imaging from the Crewe era to today. Ultramicroscopy 123, 28-37 (2012), 10.1016/j.ultramic.2012.05.005.
18. Nowotny, P., Kwon, J. M. & Goate, A. M. Alzheimer disease. eLS 1-6 (2001), 10.1038.npg.els.0000228.
19. Selkoe, D. J., Abraham, C. R., Podlisny, M. B. & Duffy, L. K. Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J Neurochem 46, 1820-1834(1986), 10.1111/j. 1471-4159.1986.tb08501.x.
20. Rostagno, A. &Ghiso, J. Isolation and biochemical characterization of amyloid plaques and paired helical filaments. Curr Protoc Cell Biol3, 1-33 (2009), 10.1002/0471143030.cb0333s44.
21. Hayne, D. J., Lim, S. & Donnelly, P. S. Metal complexes designed to bind to amyloid-beta for the diagnosis and treatment of Alzheimer's disease. Chem Soc Rev 43, 6701-6715 (2014), 10.1039/c4cs00026a.
22. Dickson, TC.&Vickers, J. C. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience 105, 99-107 (2001), 10.1016/S0306-4522(01)00169-5.
23. Kawai, M., Cras, P. & Perry, G. Serial reconstruction of [3-protein amyloid plaques: relationship to microvessels and size distribution. Brain Res 592, 278-282 (1992), 10.1016/0006-8993(92)91686-9.
24. Kuo, Y. M. et al Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains. J Biol Chem 276, 12991-12998 (2001), 10.1074/jbc.M007859200.
25. Colletier, J. P. et al Molecular basis for amyloid-beta polymorphism. Proc Natl Acad Sci USA 108, 16938-16943 (2011), 10.1073/pnas.1112600108.
26. Collingwood, J. F. et al Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J Alzheimers Dis 14, 235-245 (2008), 10.3233/JAD-18560134.
27. Condello, C, Yuan, P., Schain, A. & Grutzendler, J. Microglia constitute a barrier that prevents neurotoxic protofibrillar Abeta42 hotspots around plaques. Nat Commun 6, 6176 (2015), 10.1038/ncomms7176.
28. Friedrich, R. P. et al Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proc Natl Acad Sci USA 107, 1942-1947 (2010), 10.1073/pnas.0904532106.
29. Collingwood, J. & Telling, N. D. Iron oxides in the human brain in Iron oxides: from nature to applications (ed. Faivre, D.) ISBN 978-3-527-33882-5 (Wiley-VCH, 2016).
30. Hautot, D., Pankhurst, Q. A., Khan, N. & Dobson, J. Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue. Proc Biol Sci 270, Suppl 1, S62-S64 (2003), 10.1098/rsbl.2003.0012.
31. Kirschvink, J. L., Kobayashi-Kirschvink, A. & Woodford, B. J. Magnetite biomineralization in the human brain. Proc Natl Acad Sci USA 89, 7683-7687 (1992), 10.1073/pnas.89.16.7683.
32. Collingwood, J. &Dobson, J. Mapping and characterization of iron compounds in Alzheimer's tissue. J Alzheimer s Dis 10, 215-222 (2006).
33. Collingwood, J. R et al. In situ characterization and mapping of iron compounds in Alzheimer's disease tissue. J Alzheimers Dis 7, 267-272(2005).
34. Dong, J. et al. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 42, 2768-2773 (2003), 10.1021/bi0272151.
35. Jiang, D. et al. The elevated copper binding strength of amyloid-|3 aggregates allows the sequestration of copper from albumin: a pathway to accumulation of copper in senile plaques. Biochemistry 52, 547-556 (2013), 10.102 l/bi301053h.
36. Masters, C.L. et al Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82, 4245-4249 (1985), 10.1097/00005072-198505000-00178.
37. Everett, J. et al Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer's disease peptide beta-amyloid. Inorg Chem 53, 2803-2809 (2014), 10.1021/ic402406g.
38. Mascolo, M., Pei, Y. & Ring, T. Room temperature co-precipitation synthesis of magnetite nanoparticles in a large ph window with different bases. Materials 6, 5549-5567 (2013), 10.3390/ma6125549.
39. Teller, S., Tahirbegi, I. B., Mir, M., Samitier, J. & Soriano, J. Magnetite-Amyloid-beta deteriorates activity and functional organization in an in vitro model for Alzheimer's disease. Sci Rep 5, 17261 (2015), 10.1038/srep 17261.
40. Smith, M. A., Harris, P. L., Sayre, L. M. & Perry, G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94, 9866-9868 (1997), 10.1073/pnas.94.18.9866.
41. Faller, P. & Hureau, C. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide. Dalton Trans 21, 1080-1094 (2009), 10.1039/b813398k
42. Liihrs, T et al 3D structure of Alzheimer's amyloid-p(l-42) fibrils. Proc Natl Acad Sci USA 102, 17342-17347 (2005), 10.1073/pnas.0506723102.
43. Tomaselli, S. et al The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. Chembiochem 7, 257-267 (2006), 10.1002/cbic.200500223.
44. Midgley, P. A. &Dunin-Borkowski R. E. Electron tomography and holography in materials science. Nat Mater 8, 271-280 (2009), 10.1038/nmat2406.
45. Tonomura, A. Applications of electron holography. Rev Mod Phys 59, 639-669 (1987), 10.1103/RevModPhys.59.639.
46. Cantu-Valle, J., Ruiz-Zepeda, E, Mendoza-Santoyo, E, Jose-Yacaman, M. & Ponce, A. Calibration for medium resolution off-axis electron holography using a flexible dual-lens imaging system in a JEOL ARM 200F microscope. Ultramicroscopy 147, 44-50 (2014), 10.1016/j.ultramic.2014.06.003.
47. Volkl, E., Allard, L. E & Frost, B. A software package for the processing and reconstruction of electron holograms. JMicrosc 180, 39-50 (1995), 10.111/j.l365-2818.tb03655.x.
48. Schutz, A. K. et al The amyloid-Congo red interface at atomic resolution. Angew Chem Int Ed Engl 50, 5956-5960 (2011), 10.1002/anie.201008276.
49. Meyer, E. P., Ulmann-Schuler, A., Staufenbiel, M. & Krucker, T Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease. Proc Natl Acad Sci USA 105, 3587-3592 (2008), 10.1073/pnas.0709788105.
50. Quintana, C. & Gutierrez, L. Could a dysfunction of ferritin be a determinant factor in the aetiology of some neurodegenerative diseases? Biochim Biophys Acta 1800, 770-782 (2010), 10.1016/j.bbagen.2010.04.012.
51. Rouault, T A. Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci 14, 551-564 (2013), 10.1038/nrn3453.
52. Everett, J. et al. Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide beta-amyloid (1-42). JR Soc Interface 11, 20140165 (2014), 10.1098/rsif.2014.0165.
53. Yang, H. et al. Upregulation of mitochondrial ferritin by proinflammatory cytokines: implications for a role in Alzheimer's disease. J Alzheimers Dis 45, 797-Sll (2015), 10.3233/JAD-142595.
54. Pankhurst, Q., Hautot, D., Khan, N. & Dobson, J. Increased levels of magnetic iron compounds in Alzheimer's disease. J Alzheimers Dis 13, 49-52 (2008).
55. Singh, N., Jenkins, G.J. S., Asadi, R. &Doak, S.H. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Mmo Rev 1, 5358 (2010), 10.3402/nano.vli0.5358.
56. Riggio, C. et al. Poly-1-lysine-coated magnetic nanoparticles as intracellular actuators for neural guidance. Int J Nanomedicine 7, 3155-3166 (2012), 10.2147/ijn.s28460.
57. Almeida, T P. et al. Visualized effect of oxidation on magnetic recording fidelity in pseudo-single-domain magnetite particles. Nat Commun 5, 5154 (2014), 10.1038/ncomms6154.
58. Singamaneni, S., Bliznyuk, V. N., Binek, C. & Tsymbal, E. Y Magnetic nanoparticles: recent advances in synthesis, self-assembly and applications. J. Mater Chem 21, 16819-16845 (2011), 10.1039/C1JM11845E.
59. Vikram, S. et al. Tuning the magnetic properties of iron oxide nanoparticles by a room-temperature air-atmosphere (RTAA) co-precipitation method. J. Mmosd Nanotechnol 15, 3870-3878 (2015), 10.1166/jnn.2015.9544.
60. Tao, Y, Wang, Y, Rogers, J. T & Wang, E Perturbed iron distribution in Alzheimer's disease serum, cerebrospinal fluid, and selected brain regions: a systematic review and meta-analysis. J Alzheimers Dis 42, 679-690 (2014), 10.3233/JAD-140396.
61. Filippi, M. et al. Magnetic resonance imaging in Alzheimer's disease: from diagnosis to monitoring treatment effect. Curr Alzheimer Res 9, 1198-1209 (2012), 10.2174/156720512804142949.
62. Frisoni, G. B., Fox, N. C, Jack, C. R., Scheltens, P. & Thompson, P. M. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6, 67-77 (2010), 10.1038/nrneurol.2009.215.
63. Antharam, V. et al. High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: quantitative imaging and correlation with iron. Neuroimage 59, 1249-1260 (2012), 10.1016/j.neuroimage.2011.08.019.